Aspirin reduces risk of colon polyps recurring
2/11/2009
Top Stories
- Gene therapy edges towards commercial reality The tale of two biotech companies suggests a tricky road ahead.
- Clean living could cut one third of common cancers Healthier living could prevent about one third of the most common cancers in rich countries
- Anti-nausea drug may combat opiate addiction in people addicted to morphine, oxycodone, and other opiate drugs
- Fertility Treatments Unlikely to Raise Ovarian Cancer Risk women taking fertility drugs in order to become pregnant have not had definitive evidence that such ...
- Depression risk increased among cancer patients People who have been diagnosed with cancer are at greater risk of being hospitalized with depression
- Cold's "family tree" may lead to cure: study Researchers who mapped the DNA of more than 100 different cold viruses
- Aspirin reduces risk of colon polyps recurring For people with a history of colorectal polyps or cancer, taking aspirin is an effective way to redu...
- A Smoker is More Likely To Quit Smoking If There Are Pets A large number of pet owners who smoke would consider trying to quit for the health of their beloved...
- Multivitamins may not thwart cancer, heart disease Millions of people take a multivitamin in the hopes of averting disease, but the supplements
- Gene therapy promising for rheumatoid arthritis Researchers have successfully used gene therapy to substantially reduce joint pain in two patients w...
NEW YORK (Reuters Health) - For people with a history of colorectal polyps or cancer, taking aspirin is an effective way to reduce the chances of new polyps appearing, according to researchers in Europe and the US.
Polyps in the colon can sometimes be a precursor to the development of cancer.
Writing in the Journal of the National Cancer Institute, Dr. Bernard F. Cole, at the University of Vermont in Burlington, and his associates note that "multiple lines of evidence" suggest that aspirin has anti-cancer effects in the large bowel.
Their goal was to pool data from trials that evaluated aspirin for preventing the recurrence of colorectal polyps, in order to provide more precise estimates of aspirin's effects.
Their analysis included four trials conducted in the 1990s, involving 2698 subjects who took aspirin or an inactive "placebo" for at least a year and who underwent periodic examination by colonoscopy.
During follow-up, polyps were detected in 37 percent of 1156 participants given placebo and in 33 percent of the 1542 assigned to aspirin. Rates of advanced growths were 12 percent and 9 percent in the two groups.
While the differences might not seem large, aspirin was associated with a 17 percent lower risk for occurrence of any polyp, and 28 percent reduction in risk for advanced lesions.
"It is advantageous that aspirin is effective for preventing advanced lesions, because these lesions tend to progress more rapidly to invasive cancer," Cole's team points out.
There was no significant effect seen on the occurrence of colorectal cancer, the researchers note, because longer treatment and follow-up would be needed for such an effect to show up.
For more colon cancer news and information: http://www.yourcancertoday.com/Cancers/Colon/38
© Reuters 2006. All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks or trademarks of the Reuters group of companies around the world.
SOURCE: Journal of the National Cancer Institute, February 18, 2009;.
back to top